Selected Case Studies edited by Klaus Dembowsky and Peter Stadler
This book describes medical applications of recombinant proteins and monoclonal antibodies, some of which have already been on the market for several years while others have only recently been launched.
It also highlights the manufacturing processes for individual products, the strategies that were taken by companies in the clinical development, and the hurdles that were encountered in clinical trials and had to be overcome before approval by regulatory authorities.
More than 350 biotechnological products are currently being tested in clinical trials or are already on the market. They allow treatment regimens for diseases that thus far could not be treated adequately with conventional chemical drugs. This book illustrates strategies to modify and improve the pharmacodynamic and pharmacokinetic properties of naturally occurring proteins thus paving the way for a new era in biotechnology.
Contents:
Index
to see books of related interest
|
